Marty
Well-known member
11/7, Weise) reports that the Food and Drug Administration (FDA), "frustrated after twice asking" Celsus Laboratories to recall contaminated heparin, took the "rare step Thursday of sending U.S. marshals to seize 11 lots of the blood-thinning drug." FDA testing in January "found that large amounts of Chinese raw heparin imported into the United Sates were contaminated with the chemical oversulfated chondroitin sulfate," which the FDA believes was added to allow the product to pass tests that measure heparin levels. The seized heparin "was worth about $112,000" and represented "only a portion of the full 11 lots, which had already been shipped to other manufacturers. But because the FDA had warned those companies earlier, the drug was never used and no patients were put at risk, agency spokeswoman Karen Riley says
